PetMed Express, Inc. last reported quarterly results on Aug 13, 2026, for Q1 FY2027 (the quarter ended Jun 30, 2026): revenue of $41.0 million (-19.9% year over year) and diluted EPS of -$0.28. It usually reports 14–63 days after a quarter ends. Based on that pattern, the next release is estimated for around Oct 13, 2026.
Results for Q2 FY2027, the quarter ending around Sep 30, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Oct 14, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 14–63 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 13, 2026
44 days after quarter end
|
Q1 FY2027
ended Jun 30, 2026
|
41
-19.9%
|
-6
+82.0%
|
-0.28
+83.0%
|
|
Jun 2, 2026
63 days after quarter end
|
Q4 FY2026
ended Mar 31, 2026
|
43
-15.6%
|
-4
+65.1%
|
-0.19
+67.8%
|
|
Oct 14, 2025
14 days after quarter end
|
Q2 FY2026
ended Sep 30, 2025
|
44
-23.6%
|
-9
-466.3%
|
-0.41
-472.7%
|
|
Feb 10, 2025
41 days after quarter end
|
Q3 FY2025
ended Dec 31, 2024
|
52
-20.4%
|
-1
+65.1%
|
-0.03
+70.0%
|
|
Nov 6, 2024
37 days after quarter end
|
Q2 FY2025
ended Sep 30, 2024
|
58
-18.2%
|
2
+225.3%
|
0.11
+266.7%
|
|
Aug 6, 2024
37 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
Apr 15, 2024
15 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Feb 8, 2024
39 days after quarter end
|
—
ended Dec 31, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- PETS (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- FL
- Headquarters
- Delray Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1040130
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.